Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia

Ten-eleven translocation 1 (TET1) is a critical oncoprotein in AML. Here, the authors identify 2 compounds that target the binding of STAT3/5 specifically to the TET1 promoter, inhibiting its expression and AML cell viability.

Guardado en:
Detalles Bibliográficos
Autores principales: Xi Jiang, Chao Hu, Kyle Ferchen, Ji Nie, Xiaolong Cui, Chih-Hong Chen, Liting Cheng, Zhixiang Zuo, William Seibel, Chunjiang He, Yixuan Tang, Jennifer R. Skibbe, Mark Wunderlich, William C. Reinhold, Lei Dong, Chao Shen, Stephen Arnovitz, Bryan Ulrich, Jiuwei Lu, Hengyou Weng, Rui Su, Huilin Huang, Yungui Wang, Chenying Li, Xi Qin, James C. Mulloy, Yi Zheng, Jiajie Diao, Jie Jin, Chong Li, Paul P. Liu, Chuan He, Yuan Chen, Jianjun Chen
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/a69ded8bba8e453aab53549f9efffc05
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a69ded8bba8e453aab53549f9efffc05
record_format dspace
spelling oai:doaj.org-article:a69ded8bba8e453aab53549f9efffc052021-12-02T14:42:34ZTargeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia10.1038/s41467-017-02290-w2041-1723https://doaj.org/article/a69ded8bba8e453aab53549f9efffc052017-12-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-02290-whttps://doaj.org/toc/2041-1723Ten-eleven translocation 1 (TET1) is a critical oncoprotein in AML. Here, the authors identify 2 compounds that target the binding of STAT3/5 specifically to the TET1 promoter, inhibiting its expression and AML cell viability.Xi JiangChao HuKyle FerchenJi NieXiaolong CuiChih-Hong ChenLiting ChengZhixiang ZuoWilliam SeibelChunjiang HeYixuan TangJennifer R. SkibbeMark WunderlichWilliam C. ReinholdLei DongChao ShenStephen ArnovitzBryan UlrichJiuwei LuHengyou WengRui SuHuilin HuangYungui WangChenying LiXi QinJames C. MulloyYi ZhengJiajie DiaoJie JinChong LiPaul P. LiuChuan HeYuan ChenJianjun ChenNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-13 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Xi Jiang
Chao Hu
Kyle Ferchen
Ji Nie
Xiaolong Cui
Chih-Hong Chen
Liting Cheng
Zhixiang Zuo
William Seibel
Chunjiang He
Yixuan Tang
Jennifer R. Skibbe
Mark Wunderlich
William C. Reinhold
Lei Dong
Chao Shen
Stephen Arnovitz
Bryan Ulrich
Jiuwei Lu
Hengyou Weng
Rui Su
Huilin Huang
Yungui Wang
Chenying Li
Xi Qin
James C. Mulloy
Yi Zheng
Jiajie Diao
Jie Jin
Chong Li
Paul P. Liu
Chuan He
Yuan Chen
Jianjun Chen
Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
description Ten-eleven translocation 1 (TET1) is a critical oncoprotein in AML. Here, the authors identify 2 compounds that target the binding of STAT3/5 specifically to the TET1 promoter, inhibiting its expression and AML cell viability.
format article
author Xi Jiang
Chao Hu
Kyle Ferchen
Ji Nie
Xiaolong Cui
Chih-Hong Chen
Liting Cheng
Zhixiang Zuo
William Seibel
Chunjiang He
Yixuan Tang
Jennifer R. Skibbe
Mark Wunderlich
William C. Reinhold
Lei Dong
Chao Shen
Stephen Arnovitz
Bryan Ulrich
Jiuwei Lu
Hengyou Weng
Rui Su
Huilin Huang
Yungui Wang
Chenying Li
Xi Qin
James C. Mulloy
Yi Zheng
Jiajie Diao
Jie Jin
Chong Li
Paul P. Liu
Chuan He
Yuan Chen
Jianjun Chen
author_facet Xi Jiang
Chao Hu
Kyle Ferchen
Ji Nie
Xiaolong Cui
Chih-Hong Chen
Liting Cheng
Zhixiang Zuo
William Seibel
Chunjiang He
Yixuan Tang
Jennifer R. Skibbe
Mark Wunderlich
William C. Reinhold
Lei Dong
Chao Shen
Stephen Arnovitz
Bryan Ulrich
Jiuwei Lu
Hengyou Weng
Rui Su
Huilin Huang
Yungui Wang
Chenying Li
Xi Qin
James C. Mulloy
Yi Zheng
Jiajie Diao
Jie Jin
Chong Li
Paul P. Liu
Chuan He
Yuan Chen
Jianjun Chen
author_sort Xi Jiang
title Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
title_short Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
title_full Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
title_fullStr Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
title_full_unstemmed Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
title_sort targeted inhibition of stat/tet1 axis as a therapeutic strategy for acute myeloid leukemia
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/a69ded8bba8e453aab53549f9efffc05
work_keys_str_mv AT xijiang targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT chaohu targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT kyleferchen targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT jinie targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT xiaolongcui targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT chihhongchen targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT litingcheng targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT zhixiangzuo targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT williamseibel targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT chunjianghe targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT yixuantang targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT jenniferrskibbe targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT markwunderlich targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT williamcreinhold targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT leidong targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT chaoshen targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT stephenarnovitz targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT bryanulrich targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT jiuweilu targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT hengyouweng targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT ruisu targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT huilinhuang targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT yunguiwang targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT chenyingli targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT xiqin targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT jamescmulloy targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT yizheng targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT jiajiediao targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT jiejin targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT chongli targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT paulpliu targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT chuanhe targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT yuanchen targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
AT jianjunchen targetedinhibitionofstattet1axisasatherapeuticstrategyforacutemyeloidleukemia
_version_ 1718389650789236736